Ultragenyx Initiates Cyprus2+, a Pivotal Clinical Trial Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease

This study evaluating UX701 for the potential treatment of Wilson disease is designed with 3 seamless stages.